Alpha Tau Medical (DRTS) Preferred Stock Liabilities (2020 - 2026)
Alpha Tau Medical (DRTS) posted Preferred Stock Liabilities of $15.7 million for Q1 2026, up 194.14% sequentially from $5.4 million in Q4 2025, and up 344.23% YoY from $3.5 million in Q1 2025.
Alpha Tau Medical (DRTS) Preferred Stock Liabilities (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Preferred Stock Liabilities for 7 years, with the latest figure at $15.7 million in Q1 2026.
- Quarterly Preferred Stock Liabilities rose 344.23% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (up 344.23% YoY) and the FY2025 annual result came in at $5.4 million, up 60.4% from the prior year.
- Preferred Stock Liabilities advanced to $15.7 million in Q1 2026 per DRTS's latest filing, from $5.4 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $15.7 million in Q1 2026 and troughed at $53964.0 in Q1 2022.
- A 5-year average of $4.6 million and a median of $4.1 million in 2024 frame the typical range for Preferred Stock Liabilities.
- The sharpest annual moves came in 2023 and 2024: Preferred Stock Liabilities surged 14342.96% in 2023, then slumped 47.97% in 2024.
- Over 5 years, Preferred Stock Liabilities stood at $5.6 million in 2022, then sank by 36.11% to $3.6 million in 2023, then dropped by 7.2% to $3.3 million in 2024, then surged by 60.4% to $5.4 million in 2025, then jumped by 194.14% to $15.7 million in 2026.
- According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $15.7 million, $5.4 million, and $5.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.75 Mn |
| Dec 31, 2025 | 5.35 Mn |
| Sep 30, 2025 | 5.43 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 3.55 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 4.06 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 5.44 Mn |
| Jun 30, 2023 | 7.79 Mn |
| Mar 31, 2023 | 5.93 Mn |
| Dec 31, 2022 | 5.63 Mn |
| Sep 30, 2022 | 53,964.00 |
| Jun 30, 2022 | 53,964.00 |
| Mar 31, 2022 | 53,964.00 |
| Dec 31, 2021 | 53,964.00 |
| Dec 31, 2020 | 53,964.00 |